Microfluidics‐Driven Manufacturing and Multiscale Analytical Characterization of Nanoparticle‐Vesicle Hybrids
Advanced Healthcare Materials · 2025-02 · 14 (4)
DOI: 10.1002/adhm.202403264 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 25.12.2024. Verfasst von Jacopo Cardellini und 12 weiteren Autor:innen. Beteiligte Einrichtung: ETH Zürich, Department of Chemistry and Applied Biosciences, Institute for Chemical and Bioengineering, 8093, Zürich, Switzerland. Hauptthemen laut MEDLINE: Nanoparticles, Liposomes, Extracellular Vesicles, Microfluidics. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: BOW.
Abstract (Originalsprache)
Coating synthetic nanoparticles (NPs) with lipid membranes is a promising approach to enhance the performance of nanomaterials in various biological applications, including therapeutic delivery to target organs. Current methods for achieving this coating often rely on bulk approaches which can result in low efficiency and poor reproducibility. Continuous processes coupled with quality control represent an attractive strategy to manufacture products with consistent attributes and high yields. Here, this concept is implemented by developing an acoustic microfluidic device together with an analytical platform to prepare nanoparticle‐vesicle hybrids and quantitatively characterize the nanoparticle coverage using fluorescence‐based techniques at different levels of resolution. With this approach polymethyl methacrylate (PMMA) nanoparticles are successfully coated with liposomes and extracellular vesicles (EVs), achieving a high encapsulation efficiency of 70%. Moreover, the approach enables the identification of design rules to control the efficiency of encapsulation by tuning various operational parameters and material properties, including buffer composition, nanoparticle/vesicle ratio, and vesicle rigidity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- ETH Zürich, Department of Chemistry and Applied Biosciences, Institute for Chemical and Bioengineering, 8093, Zürich, Switzerland.
- Department of Chemistry "Ugo Schiff," University of Florence, 50019 Florence, Italy.
- Nanotechnology and Magnetism Lab - NANOMAG, Materials Institute - iMATUS, Health Research Institute - IDIS, Department of Applied Physics, Universidade de Santiago de Compostela, 15782, Santiago, Spain.
- Nanostructured Materials Group, International Iberian Nanotechnology Laboratory (INL), Avenida Mestre Jose Veiga, Braga, 4715-330, Portugal.
- Cell-Tech HUB at Institute for Research and Biomedical Innovation, National Research Council of Italy (CNR), 90146 Palermo, Italy.
- Department of Molecular and Translational Medicine, Università degli Studi di Brescia, Viale Europa 11, 25123, Brescia, Italy.
ORCID-Profile: Jacopo Cardellini, Paolo Arosio
Förderung
- BOW
Zitieren
APA
Cardellini, J., Normak, K., Gerlt, M., Makasewicz, K., Seiffert, C., Capasso Palmiero, U., Ye, S., González Gómez, M. A., Piñero, Y., Rivas, J., Bongiovanni, A., Bergese, P., & Arosio, P. (2025). Microfluidics‐Driven Manufacturing and Multiscale Analytical Characterization of Nanoparticle‐Vesicle Hybrids. Advanced Healthcare Materials, 14(4). https://doi.org/10.1002/adhm.202403264
Vancouver
Cardellini J, Normak K, Gerlt M, Makasewicz K, Seiffert C, Capasso Palmiero U, et al. Microfluidics‐Driven Manufacturing and Multiscale Analytical Characterization of Nanoparticle‐Vesicle Hybrids. Advanced Healthcare Materials. 2025;14(4). doi:10.1002/adhm.202403264
BibTeX
@article{Cardellini2025,
author = {Cardellini, Jacopo and Normak, Karl and Gerlt, Michael and Makasewicz, Katarzyna and Seiffert, Charlotte and Capasso Palmiero, Umberto and Ye, Suiying and González Gómez, Manuel A and Piñero, Yolanda and Rivas, José and Bongiovanni, Antonella and Bergese, Paolo and Arosio, Paolo},
title = {Microfluidics‐Driven Manufacturing and Multiscale Analytical Characterization of Nanoparticle‐Vesicle Hybrids},
journal = {Advanced Healthcare Materials},
year = {2025},
volume = {14},
number = {4},
doi = {10.1002/adhm.202403264}
}
EUVIMED